CTLA4 and neoplasm: In two mouse models of breast (4T1) and colon (CT26) cancer, MWA of primary tumours followed by combined anti-PD-1 and anti-CTLA-4 treatment resulted in prolonged survival compared with MWA or ICPIs alone.